📊 Biological components in conditioned media are a consistent problem during downstream processing of MSC-EVs. Novel AgentV™-DSP prevents filters blocking and EV loss at every step while maintaining CQAs. Download this poster to learn more: roosterbio.com/resource/scala…

🗓️ Join our upcoming webinar, Cell Bank & Scale Up Strategies for MSC & Exosome Manufacturing, on 7/23 at 11AM (ET). This webinar will walk you through how to accelerate cell and exosome manufacturing for clinical and commercial programs. Register here➡️ us02web.zoom.us/webinar/regist…

A close relative of MSCs, Fibroblasts can have overlapping morphology, surface markers, and even differentiation potential. But there are more subtle differences between these 2 cell types than meets the eye. Is there a best-fit candidate for your program? roosterbio.com/blog/deference…

🗓️By utilizing scalable solutions & established processes, advanced therapy programs can meet the increased cell and exosome needs of clinical progression. Join our webinar on Cell Bank & Scale Up Strategies for MSC & Exosome Manufacturing to learn more.➡️ us02web.zoom.us/webinar/regist…

MSCs are proving their worth as adaptable, scalable building blocks for next-gen organ-on-a-chip systems. These chips promise better human-relevant models, less reliance on animal testing, and faster drug development. Check out this blog to learn more➡️ roosterbio.com/blog/how-hmscs…

In this study, we developed and qualified a CD73 bioactivity assay that assesses the potency of EVs by measuring AMP-to-adenosine conversion. This assay provides a robust standardized method for evaluating EV bioactivity & supports GMP-compliant testing.➡️ roosterbio.com/resource/eleva…

To meet growing demand, RoosterBio has developed a xeno-free, scalable hMSC bioreactor process that maintains critical quality attributes and can be implemented in the pbs_biotech Vertical-Wheel® Bioreactor platform for a uniform, low-shear environment.⤵️ hubs.ly/Q03zjrvG0

📑Researchers from Health Canada and PHAC and Université d'Ottawa | University of Ottawa evaluated whether human mesenchymal stromal cells (hMSCs) are a good model for chemical toxicity testing, using inorganic arsenic as a case study. RoosterBio cells and media were used to support their work. 🔗…iencejournals.onlinelibrary.wiley.com/doi/epdf/10.10…

Looking ahead, rigorous characterization will allow extracellular vesicle-based discoveries to move toward clinical applications with clarity and credibility. This blog explores "The spirit of MISEV," a distillation of best practices for EV researchers.⤵️ hubs.ly/Q03zD21w0

RoosterBio’s Exosome Analytical Services have expanded to include tools for single vesicle analysis. Quantitative & multiparametric analysis of individual exosomes provides deeper insight into size distribution, concentration, & surface marker expression. hubs.ly/Q03Bl2j90

📊Check out our study on a calibrated NanoFlow cytometry method to quantify surface marker expression on single Extracellular Vesicles, enabling high-resolution profiling. This analysis supports the development of targeted EV-based therapies and products. roosterbio.com/resource/singl…

📊This comparative analysis of MSC-EVs from bone marrow, umbilical cord, and adipose tissue across multiple production platforms helps to understand challenges in scalability. It compares particle number, size distribution, purity, CD73 activity, and more. roosterbio.com/resource/analy…

Publication Spotlight! 💡 Remove the uncertainty from your scale-up and differentiation process development with this MSC, MSC-EV scale-up protocol. RoosterBio Read the FULL publication here: hubs.li/Q03Cv1vC0 #PBSBiotech #MSCs #EVs #ScaleUp #Bioprocess

This blog breaks down RoosterBio's webinar earlier this year on MSC-EV bioprocessing — highlighting how tissue source, donor variability, and 3D culture platforms influence EV yield and quality. Read the step-by-step breakdown here.⤵️ roosterbio.com/blog/when-data…

AgentV™-DSP is helping "change the tune" for cell therapies and bioproduction, offering 10X greater efficiency for exosome manufacturing. Read how this downstream processing treatment can significantly improve exosome yield while maintaining quality. ➡️ roosterbio.com/blog/to-10x-be…

This collaborative study between RoosterBio & BioSpherix, LLC shows that the oxygen microenvironment profoundly affects the miRNA cargo of MSC-EVs. Its findings support oxygen tuning as a critical lever for optimizing EV therapeutic potency. Download it here⤵️ roosterbio.com/resource/oxyge…